Edition:
India

Insider Trading: CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

7.40USD
18 Sep 2020
Change (% chg)

$0.22 (+3.06%)
Prev Close
$7.18
Open
$7.27
Day's High
$7.44
Day's Low
$7.05
Volume
464,865
Avg. Vol
222,699
52-wk High
$15.43
52-wk Low
$3.60

All Insider Trades
Trading Date Name Title Type Shares Traded Price
29 May 2020

McCarthy (Sean A Ph.D.)

Chief Executive Officer Buy 1,158 $5.11
12 May 2020

McCarthy (Sean A Ph.D.)

Chief Executive Officer Buy 36,000 $1.13
12 May 2020

McCarthy (Sean A Ph.D.)

Chief Executive Officer Sell 36,000 $15.00
30 Nov 2019

McCarthy (Sean A Ph.D.)

Chief Executive Officer Buy 1,080 $5.32
31 May 2019

Knifsend (Robin)

Officer Buy 1,812 $8.21
31 May 2019

McCarthy (Sean A Ph.D.)

Chief Executive Officer Buy 695 $8.21
31 May 2019

ROWLAND LLOYD A

General Counsel Buy 1,812 $8.21
10 Apr 2019

Gluck (Frederick W)

Director Gift 3,900 $0.00
8 Apr 2019

Gluck (Frederick W)

Director Gift 3,900 $0.00
4 Mar 2019

ROWLAND LLOYD A

General Counsel Buy 9,000 $10.33
12 Dec 2018

Ray (Debanjan)

Chief Financial Officer Buy 3,000 $1.45
12 Dec 2018

Ray (Debanjan)

Chief Financial Officer Sell 3,000 $15.00
30 Nov 2018

ROWLAND LLOYD A

General Counsel Buy 979 $11.73
30 Nov 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Buy 468 $11.73
2 Nov 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Buy 1,156 $1.57
2 Nov 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Sell 1,156 $15.01
1 Nov 2018

Ray (Debanjan)

Chief Financial Officer Sell 3,000 $15.00
1 Nov 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Sell 5,270 $15.00
1 Nov 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Buy 5,370 $1.57
1 Nov 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Sell 100 $15.01
1 Nov 2018

Ray (Debanjan)

Chief Financial Officer Buy 3,000 $1.45
1 Oct 2018

Ray (Debanjan)

Chief Financial Officer Buy 3,000 $1.45
1 Oct 2018

Ray (Debanjan)

Chief Financial Officer Sell 3,000 $18.46

Institutional Holders

% Shares Owned: 84.55%
# of Holders: 205
Total Shares Held: 39,056,103
3 Mo. Net Change: 1,666,797
# New Positions: 41
# Closed Positions: 17
# Increased Positions: 109
# Reduced Positions: 65
# Net Buyers: 44

Officers & Directors

Name Age Since Current Position

Sean McCarthy

53 2019 Chairman of the Board, President, Chief Executive Officer

Carlos Campoy

55 2020 Chief Financial Officer, Senior Vice President

Amy Peterson

53 2019 Executive Vice President, Chief Development Officer

W. Michael Kavanaugh

63 2015 Senior Vice President, Chief Scientific Officer and Head - Research and Non-Clinical Development

Lloyd Rowland

63 2018 Senior Vice President, Chief Compliance Officer, General Counsel, Secretary

Nick Galli

2019 Senior Vice President, Chief Business Officer

Alison Hannah

59 2020 Senior Vice President, Chief Medical Officer

Matthew Young

50 2018 Lead Independent Director

Charles Fuchs

59 2017 Independent Director

Halley Gilbert

50 2020 Independent Director

Frederick Gluck

84 2010 Independent Director

Elaine Jones

65 2019 Independent Director

James Meyers

54 2018 Independent Director

John Scarlett

69 2016 Independent Director

Christopher Keenan

2018 Vice President, Investor Relations and Corporate Communications